设为首页 收藏本站 切换到宽版
登录 注册

电子烟成畅销戒烟品,大型制药公司坐不住了!

0
回复
309
查看
[复制链接]

微信扫一扫 分享朋友圈

502

主题

504

帖子

5496

积分
发表于 2016-4-12 15:20:23 | 显示全部楼层 |阅读模式
Vaping(电子烟)已经成为了时下最热门畅销的戒烟/替烟产品,对此大型制药公司表示“很不淡定”!
据Daily Caller(美国自由主义新闻网站)一篇文章报道,伦敦大学学院一项研究证明:2015年有一百万英格兰烟民使用电子烟来戒烟,这就意味着去年戒烟成功的260万人中,其中大约40%的人是使用电子烟的。
罗伯特·韦斯特,伦敦大学学院健康心理学教授,早在2014年,针对那些想戒烟的烟民就做过此类证明vape电子烟相关的影响研究。
韦斯特指出,vaping(电子烟)能显著提高长期戒烟的成功率,使得戒烟比例从5%增加至7.5%。
这项研究证明vaping在电子烟圈内已经卓有成效,相反大型制药公司出产的传统类型尼古丁戒烟产品则不那么尽如人意。
QQ截图20160412151907.png
◆ 制药公司的“困扰” ◆  
为什么电子烟的流行会对大型制药公司造成困扰?因为去年只有略多于25%的吸烟者会采用传统的尼古丁产品来戒烟,而这些尼古丁产品都是由制药公司出售的。这就意味着这些大型制药公司会因电子烟行业而损失一大笔钱,而且他们也预料到vaping作为可行的替烟选择会致使他们失去更多的收益。
同时,大型制药公司在针对电子烟监管方面多次从事误导宣传性的活动,来抑制电子烟日益蒸蒸日上的发展势头;就在2014年,一组公开的邮件显示某最大制药公司在广泛游说并主张严格管控电子烟。索菲·克鲁斯,葛兰素史克(某著名制药公司)消费保健部门的欧洲公共事务副总裁,在E-mail中标榜:“我们认为所有含尼古丁产品都应当像医用品一样被适当监管。”
QQ截图20160412151915.png
◆    ◆    ◆    ◆    ◆    ◆    ◆    ◆
虽然由大烟草和大制药公司“导演”的研究会继续“上头条”,但是vaping(电子烟)人士自发组织共同打造的一部纪实片《十亿条生命》,将会于今年晚些时候发布。纪录片旨在从一个公开视角观察为什么大型制药公司及其盟友要试图“抹掉”电子烟。
对于所有的Vaping社交圈而言,大型制药公司的“阻力”将会是一个标志,指引着我们朝着正确的方向前进;远离烟草,努力成为一个更健康、更安全的选择。
Vaping(电子烟)正变得更加主流和为人所接受,监管的“暗斗”持续升温,所以敬请关注更多的vaping(电子烟)消息。
(原文略有改动)

原 文
Big Pharma Worried As Vaping Takes Top Spot In Quitting
Vaping has officially become the most popular way to quit smoking, and Big Pharma is worried.
According to an article from the Daily Caller, the University College of London conducted a study that showed one million smokers in England kicked smoking with the use of vaping products in 2015. That means that out of the 2.6 million people who kicked the habit last year, about 40 percent of them used vaping to do so.
Robert West, who is a professor of health psychology at University College London and associated with a similar study, done in 2014, remarked at the impact vaping has had on those who have been wanting to quit smoking.
West noted that vaping significantly increased the long-term rate of success of quitting smokers, moving the percentage from five percent to 7.5 percent.
The studies proving vaping’s effectiveness has been a boon for the vaping public and pro-vaping advocates. But it has not fared so well in the eyes of the pharmaceutical companies that create and sell the nicotine products that are traditionally used to quit smoking.
Why is this a problem for Big Pharma? Because only slightly more than 25 percent of people in England who tried to quit last year — roughly half a million — used licensed nicotine products, which are sold by pharmaceutical companies. That means that Big Pharma lost a good amount of money to the vaping industry, and they can only expect to lose more money as vaping gains strength as a viable alternative to smoking.
And the claims that Big Pharma is engaging in misinformation campaigns aimed at strict regulation of vaping — or bans on vaping in general — have only gained steamed in recent years. In 2014, a set of emails were made public that showed one of the biggest pharmaceutical companies lobbying for extensive regulation on vaping.
Sophie Crousse, the vice president of European public affairs for Glaxo Smith Kline’s consumer healthcare division, was quoted in the emails as saying, “We believe in responsible and proportionate regulation for all nicotine-containing products as medicinal products.”
And while studies backed by Big Pharma and Big Tobacco continue to make headlines, vaping advocates have come together to create a documentary aimed at unearthing the claims by these behemoths. A Billion Lives, slated for release later this year, is described as an expose aimed at looking at how and why Big Pharma and its allies are trying to eliminate vaping.
For all those in the vaping community, the push-back from Big Pharma is a sign that we’re heading in the right direction — away from Big Tobacco and towards a healthier and safer alternative. As vaping becomes more mainstream and accepted, the fight to regulate it is heating up, so stay tuned for more vaping news.

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

QQ| Archiver|手机版|小黑屋| 商务合作电话:15534039991 | 邮箱:469259535@qq.com | QQ:2066178201| 蒸汽烟吧! ( 晋ICP备16001084号 )  

快速回复 返回顶部 返回列表